How a supplement company became a haven for health misinformation
On a Friday afternoon in July, as many New Yorkers fled the scorching city streets,…
Author: STAT
STAT+: Why Novartis is changing the name of its research labs
Swiss drugmaker Novartis’ research and development hub has a new name — and a new…
An uncommon thyroid diagnosis led to an unexpected, all-too-visible side effect
Annie Larsson, 40, is no stranger to chronic conditions. She was diagnosed with type 1…
Opinion: STAT+: Sanofi CEO Paul Hudson: The right way to bring AI into pharma
While it’s widely accepted that the pharma industry is innovative in R&D, it is also…
Opinion: How the drug price negotiation program could affect Medicare Part D beneficiaries
After the recent announcement of the first 10 drugs selected for Medicare price negotiation, much…
Group behind ProMED fires three top moderators amid strike
The organization that runs the infectious diseases surveillance system ProMED terminated at least three of…
Back to school for biotech, Biogen’s potential pivot, & Illumina’s next chapter
Are there still too many biotech companies? How do you know when you’re in a…
Trump surgeon general admits Trump White House made mistakes during Covid
The Trump administration made some serious missteps during the coronavirus pandemic, Trump’s top doctor Jerome…
.jpg)
Biotech execs vie for a share of obesity drug boom: ‘It’s the early innings’
Pharma giants Novo Nordisk and Eli Lilly might’ve led the way into a new era…
.jpg)
STAT+: Amazon’s chief medical officers on where the company’s health care bets are headed next
The graveyard is littered with Amazon’s bets in health care: wearables, Care, the ill-fated Haven….
A new House health package & hospitals’ new site-neutral talking points
You’re reading the web edition of D.C. Diagnosis. Sign up here to receive this newsletter in your…
What could fix cancer clinical trials’ longstanding diversity problem?
There’s a diversity problem in cancer clinical trials, and few know this better than Stephanie…
STAT+: Pharmalittle: South Africa ‘bullied’ into one-sided Covid vaccine deals; Astellas drops Medicare price-negotiation suit
Good morning, everyone. Jason Mast here filling in for Ed. I learned today from TikTok…
STAT+: In boon for scientists, U.K. strikes deal to join E.U. Horizon research program
The U.K. has reached a deal to join the E.U.’s landmark Horizon research initiative, a…
Not yet free from heroin’s grip, an ‘honest, funny man’ finds his way off the streets
PHILADELPHIA — Shaun Anderson hasn’t slept this late in the day in years. He still…
Opinion: How health care systems can protect patients from sexual assault by providers
Health care providers have a sacrosanct relationship with patients. That unique position of trust also…
STAT+: Why the drug industry’s opaque warnings on price negotiations fall short
Ever since Medicare was given power to negotiate prices for certain medicines, the pharmaceutical industry…
Opinion: What a viral study criticizing cancer screening gets very, very wrong
A recent study prompted CNN to report, “Most cancer screenings don’t ultimately give someone extra…
Ketamine can be transformative for people with suicidal thoughts — if they can access it
Every day, Marisa Russello was overwhelmed by suicidal thoughts. Even one negative thought might cause…
STAT+: AstraZeneca CEO Pascal Soriot proposes a novel fix to the drug pricing bill’s alleged cancer problem
Among the pharmaceutical companies’ many objections to the Biden administration’s drug pricing program is a…
STAT+: Cancer care appears brighter as off-the-shelf CAR-T advances
If you ask biopharma leaders what’s ahead for CAR-T cancer therapy, they say the future…
STAT+: South Africa was forced into ‘one-sided’ deals with Covid-19 vaccine suppliers, contracts reveal
South Africa was “bullied” into signing one-sided contracts with Covid-19 vaccine suppliers that forced the…
Opinion: What does ‘bona fide competition’ actually mean in the biologics market?
On Aug. 29, Medicare released its highly anticipated list of 10 therapies for which it…
Robert Winn: Without ‘high-touch’ strategies, cancer’s breakthroughs will increase disparities
Looking at the dizzying progress in cancer medicine over the last couple of decades, it’s…
STAT+: House committees strike deal on health transparency, PBM reform package
WASHINGTON — Republicans on three key House committees have reconciled their differing legislative packages to…
STAT+: Covid hospitalizations on the rise, Humana says
More older adults have been hospitalized for Covid-19 over the past several weeks, according to…
STAT+: Astellas withdraws lawsuit after evading Medicare drug price negotiations
WASHINGTON — Astellas was so sure that one of its drugs was going to be…
STAT+: Nimbus Therapeutics raises $210 million in one of the larger fundraising rounds this year
Seven months after Nimbus Therapeutics sold an experimental autoimmune disease medicine to Takeda Pharmaceuticals for up to…
STAT+: Pharmalittle: Novartis is losing its chief commercial officer; vaccine experts urge more inclusivity in clinical trials
Top of the morning to you. And a steamy one, it is. In fact, there…
With affirmative action off the table, medical schools plan new diversity tactics
“Lots of scrambling on the ground.” That’s how Consuelo Wilkins, the senior associate dean for…
Opinion: I cured my ARFID with psilocybin. I shouldn’t have needed to self-treat it
For 27 years, I tried to make myself eat vegetables. Last fall, I ate my…
How a conservative, gun-toting doctor defended abortion access in Appalachia
BRISTOL, Va. — When Wes Adams’ youngest son was little, he’d sometimes toddle over to…
Three lessons from Covid that could help global leaders prevent the next pandemic
Everyone has things that, looking back, they would have done differently in the early days…
Vaccine experts urge more inclusivity in clinical trials
The recently approved RSV vaccines have been celebrated as key public health tools, but some…
Information blocking fines are now fair game in health care
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
STAT+: Pharmalittle: Novartis is latest drugmaker to sue over Medicare negotiations; Illumina names a new CEO
Good morning, everyone, and welcome to another working week. We hope the weekend respite —…
STAT+: Illumina names Agilent executive as new CEO
Illumina, the largest maker of DNA-sequencing technology and a storied name in the biotechnology industry,…
Republicans say they’ll stop fentanyl at the border. But what are their plans for treatment?
Americans are dying of fentanyl overdoses in record numbers, and the Republican presidential candidates are…
STAT+: Graduate students accuse University of California of wage theft, just months after strike was settled
University of California graduate students were thrilled last December when they won what they thought…
STAT+: Generative AI Tracker: A guide to the health systems and companies driving adoption
Health care leaders and technology companies are investing heavily in large language models, a powerful…
Opinion: The question list is a simple way to help patients prepare for appointments
The term for a patient who lists their questions was likely coined in the late…
Opinion: Looking for a climate job? Consider biotech
More and more people, especially early career workers, want jobs fighting climate change. But when…
STAT+: Moving beyond ChatGPT: How generative AI is inspiring dreams of a health data revolution
The world’s largest technology companies are racing to build generative AI into every corner of…
STAT+: Humana sues Biden administration over Medicare Advantage audit rule
Humana sued the federal government Friday, arguing that this year’s new rule to claw back…
How a ‘weighted lottery’ helped underserved patients get a scarce Covid drug
In the midst of the Covid-19 surge during the winter of 2021, the Pittsburgh-based UPMC…
STAT+: FTC settles with Amgen over $28 billion deal for Horizon
After months of legal sparring, Amgen and Horizon Therapeutics settled a lawsuit with the U.S….
STAT+: Pharmalittle: How 98 days may cost J&J big bucks; Walgreens CEO departs
And so, another working week will soon draw to a close. Not a moment too…
Opinion: Why isn’t there any enforcement of the ACA mandate to support breastfeeding?
Eleven years ago, the Affordable Care Act codified a critical aspect of postpartum care: breastfeeding…
STAT+: AstraZeneca bets that gene therapy’s workhorse will still deliver the goods
Seng Cheng has been working in gene therapy for nearly as long as gene therapy…
STAT+: The curious case of J&J’s Stelara, the unluckiest drug on Medicare’s list
WASHINGTON — Ninety-eight days may end up costing Johnson & Johnson. When Medicare this week…